However, when tumor subtypes were analyzed, there was statistically significant increased risk of serous carcinomas in BRCA1 mutation carriers (observed to expected ratio of 22.2, 95%CI: [6.1,56.9], P < 0.001). The gene discussed is BRCA1; the disease is serous adenocarcinoma.